Browsing Pathways
Showing 167181 -
167190 of 605359 pathways
PathBank ID | Pathway Name and Description | Pathway Class | Chemical Compounds | Proteins |
---|---|---|---|---|
SMP0129802View Pathway |
Zanidatamab Drug MetabolismHomo sapiens
|
Metabolite
Metabolic
|
|
|
SMP0130196View Pathway |
Zansecimab Drug MetabolismHomo sapiens
|
Metabolite
Metabolic
|
|
|
SMP0129400View Pathway |
Zanthoxylum clava-herculis bark Drug MetabolismHomo sapiens
|
Metabolite
Metabolic
|
|
|
SMP0129374View Pathway |
Zanthoxylum clava-herculis whole Drug MetabolismHomo sapiens
|
Metabolite
Metabolic
|
|
|
SMP0130872View Pathway |
Zanubrutinib Drug MetabolismHomo sapiens
Zanubrutinib is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Zanubrutinib passes through the liver and is then excreted from the body mainly through the kidney.
|
Metabolite
Metabolic
|
|
|
SMP0145237View Pathway |
Zanubrutinib Drug Metabolism Action PathwayHomo sapiens
|
Metabolite
Drug Action
|
|
|
SMP0128232View Pathway |
Zea mays pollen Drug MetabolismHomo sapiens
|
Metabolite
Metabolic
|
|
|
SMP0122765View Pathway |
Zeatin BiosynthesisArabidopsis thaliana
Zeatin encourages lateral bud growth, resulting in bushier plants. It stimulates cell division when sprayed on meristems. Terpenoid backbone biosynthesis produces dimethylallyl diphosphate which, with different reactants, can result in different products with a byproduct of diphosphate. When reacted with tRNA adenine via tRNA dimethylallyltransferase, it results in the formation of tRNA containing 6-isopentenyl adenosine. When reacted via adenylate isopentenyltransferase 1, chloroplastic with either ATP, ADP, or AMP, it results in the formation of the corresponding isopentenyl, which in turn reacts with oxygen and reduced NADPH hemoprotein reductase via cytokinin hydroxylase, resulting in the formation of trans-zeatin riboside with the corresponding phosphates and byproducts of water and oxidized NADPH hemoprotein reductase.
|
Metabolite
Metabolic
|
|
|
SMP0012034View Pathway |
Zeaxanthin BiosynthesisArabidopsis thaliana
Zeaxanthin biosynthesis is a pathway that occurs in the chloroplast by which lycopene becomes zeaxanthin, one of the most common carotenoid alcohols found in nature . The first two reactions are catalyzed by lycopene beta cyclase which uses NAD(P)H as a cofactor to convert lycopene into gamma-carotene and gamma-carotene into beta-carotene. The last two reactions are catalyzed by beta-carotene 3-hydroxylase which uses ferredoxin and Fe2+ as cofactors to convert beta-carotene into beta-cryptoxanthin and beta-cryptoxanthin into zeaxanthin.
|
Metabolite
Metabolic
|
||
SMP0130886View Pathway |
Zeaxanthin Drug MetabolismHomo sapiens
Zeaxanthin is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Zeaxanthin passes through the liver and is then excreted from the body mainly through the kidney.
|
Metabolite
Metabolic
|
Showing 167181 -
167190 of 167265 pathways